Pharma Journalist -

TrialScope has announced the launch its second Clinical Trial Disclosure Maturity Survey for clinical trial sponsors to perform self-assessments of their disclosure practices. The…
Read More...

miRagen Therapeutics announced that  MRG-106 has received orphan medicinal product designation from European Commission (EC) for the treatment of cutaneous T-cell lymphoma (CTCL). CTCL…
Read More...

Sun Pharmaceutical Industries announced that USFDA has accepted BLA for tildrakizumab submitted by Merck & Co., USA. The FDA filing acceptance follows acceptance of the regulatory…
Read More...

KBI Biopharma announced that they have planned to invest $30M for expanding its biopharmaceutical manufacturing capacity at both its Durham, NC, and Boulder, CO, facilities. KBI is…
Read More...

Selexis SA and OSE Immunotherapeutics announced that they have signed a commercial license agreement that provides OSE Immunotherapeutics with access to high performance research cell…
Read More...

Pierre Fabre announced that they signed a definitive purchase agreement with Igenica Biotherapeutics to acquire several of Igenica assets. The agreement includes innovative…
Read More...

LSNE Contract Manufacturing announced that it has signed a manufacturing supply agreement with Selecta Biosciences to support the development of biologic therapies for rare and serious…
Read More...

Intellipharmaceutics International announced that its U.S. marketing partner, Par Pharmaceutical has launched the 10 and 20 mg strengths of its generic Focalin XR (dexmethylphenidate…
Read More...

Hebron Technology won a bid on the design and implementation of an oil-free compressed air pipe project at a pharmaceutical production facility owned by Tianjin Chase Sun…
Read More...

AstraZeneca announced that its Bydureon phase IIIb/IV EXSCEL (EXenatide Study of Cardiovascular Event Lowering) trial top-line results and met its primary safety objective of…
Read More...